With respect to solid tumors, MCL-1 inhibition was effective in a subset of SCLC cell lines with high MCL-1 and low BCL-XL expression, including in a patient-derived cell line xenograft model in vivo [168]. This evidence concerns the gene MCL1 and small cell lung carcinoma.